Stem Cell Therapy Market : Comprehensive Analysis of Latest Trends and Developments| Celgene Corp. (Bristol Myers Squibb), ReNeuron Group PLC, BioTime Inc., Mesoblast Ltd., Seneca Biopharma Inc., Opexa Therapeutics Inc., Pluristem Therapeutics Inc., STEMC

Global Stem Cell Therapy Market Analysis and Forecast 2019-2028

The global stem cell therapy market is projected to grow at a CAGR of over 8% during the forecast period. The market growth is attributed to the rising prevalence of rare genetic illnesses. Rare disorders such as thalassemia, , cystic fibrosis, and others affect millions of individuals each year. According to World Health Organization (WHO), chronic diseases cause 41 million mortalities every year, equivalent to 71% of all mortalities globally. Furthermore, developments in stem cell therapies that improve the pace of recovery in cancer patients are projected to increase their demand. Significant government funding and initiatives for regenerative medicine research and development activities in the developed region will further drive the market growth.

Request Sample Copy @ https://www.themarketinsights.com/request-sample/265119

Market Segmentation

The global stem cell therapy market has been analyzed on the basis of product, therapy type, technology, therapeutic application, end use, and region. Based on the product, the market is segmented into adult stem cells (ASCs), human embryonic stem cells (HESCs), induced pluripotent stem cells (iPSCs), and very small embryonic-like stem cells. Among these, ASCs segment is estimated to hold a prominent share in the market. Based on therapy type, the market is segmented into allogeneic stem cell therapy and autologous stem cell therapy. Among these, allogeneic stem cell therapy is estimated to hold a prominent share in the market.
Based on technology, the market is segmented into cell acquisition, cell production, cryopreservation, and expansion and sub-culture. Among these, cell production is estimated to grow at a significant rate during the forecast period. Based on therapeutic application, the market is segmented into oncology, orthopedic, neurology, cardiovascular & myocardial infraction, hematology, and others. Among these, oncology segment is estimated to hold a prominent share while neurology is projected to exhibit remarkable growth during the forecast period. Further, on the basis of end use, the market covers the analysis of hospitals and research organization. Geographically, the market is analyzed into North America, Western Europe, Eastern Europe, Asia Pacific, Latin America, and Middle East & Africa.

Check for Discount @ https://www.themarketinsights.com/check-discount/265119

Market Structure and Competition Landscape
The growth of the global stem cell therapy market is characterized by the presence of players operating in the market. Some of the players operating in the market include
Celgene Corp. (Bristol Myers Squibb),
ReNeuron Group PLC,
BioTime Inc.,
Mesoblast Ltd.,
Seneca Biopharma Inc.,
Opexa Therapeutics Inc.,
Pluristem Therapeutics Inc.,
STEMCELL Technologies Inc.,
ThermoGenesis Holdings Inc.,
Astellas Pharma Inc.,
and Caladrius Biosciences Inc.
among others. To grow their business, companies use techniques including new product launches, mergers and acquisitions, partnership and collaborations, etc.
In March 2021, NOVADIP Biosciences S.A. received FDA approval for its Investigational New Drug (IND) application for its autologous cell treatment product NVD-003. This strategy is expected to boost their market position by improving their product offerings and expanding their consumer base.
In April 2020, Seneca Biopharma Inc. announced the completion of its new cell manufacturing facility in Suzhou, China. The company will manufacture NSI-566 in this new facility, which is the company s leading stem cell therapy.

Report Customization available as per requirements @ https://www.themarketinsights.com/request-customization/265119

Table of Content

Chapter One: Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation
Chapter Two: Assumptions and Acronyms
Chapter Three: Executive Summary
3.1. Global Market in2022
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends
Chapter Four: Research Methodology
Chapter Five: Analysis of COVID-19 Impact and Road Ahead
Chapter Six: Market Indicators and Background
6.1. Macro-Economic Factors
6.1.1. Global Population Overview and Forecast
6.1.2. Global Stem Cell Therapy Professionals in the select countries
6.2. Forecasting Factors
Robust assessment of various factors including industrial performance, healthcare expenditures, industry players expenditures, economic conditions, among others
6.3. Supply Chain & Value Chain Analysis
6.4. Industry SWOT Analysis
6.5. PESTLE Analysis
6.6. Porter s Five Forces Analysis
Chapter Seven: Government Laws and Industry Regulations
Chapter Eight: Global and Regional Market Dynamics
8.1. Drivers
8.2. Restraints
8.3. Trends
8.4. Opportunities
Chapter Nine: Global Stem Cell Therapy Market: Key Investment Analysis
9.1. By Key Industry Players
9.2. By Therapy Type
9.3. By Therapeutic Application
9.4. By Region
9.5. M&A Activities
Robust assessment of major investments made by various industry players along with key therapeutic application areas, therapy type, and key region
Chapter Ten: Pricing Analysis
10.1. By Therapy Type
10.1.1. Allogeneic Stem Cell Therapy
10.1.2. Autologous Stem Cell Therapy
10.2. By Region
10.2.1. North America
10.2.2. Western Europe
10.2.3. Eastern Europe
10.2.4. Asia Pacific
10.2.5. Latin America
10.2.6. Middle East & Africa
Chapter Eleven: Parent Market Overview: Global Healthcare & Life Sciences Market
Chapter Twelve: Segmental Analysis
12.1. Global Stem Cell Therapy Market by Product
12.1.1. Segment Overview
12.1.1.1. Adult Stem Cells (ASCs)
12.1.1.1.1. Hematopoietic
12.1.1.1.2. Mesenchymal
12.1.1.1.3. Neural
12.1.1.1.4. Others (Epithelial/Skin)
12.1.1.2. Human Embryonic Stem Cells (HESCs)
12.1.1.3. Induced Pluripotent Stem Cells (iPSCs)
12.1.1.4. Very Small Embryonic-Like Stem Cells
12.2. Global Stem Cell Therapy Market by Therapy Type
12.2.1. Segment Overview
12.2.1.1. Allogeneic Stem Cell Therapy
12.2.1.2. Autologous Stem Cell Therapy
12.3. Global Stem Cell Therapy Market by Technology
12.3.1. Segment Overview
12.3.1.1. Cell Acquisition
12.3.1.1.1. Bone Marrow Harvest
12.3.1.1.2. Umbilical Blood Cord
12.3.1.1.3. Apheresis
12.3.1.2. Cell Production
12.3.1.2.1. Therapeutic Cloning
12.3.1.2.2. In-vitro Fertilization
12.3.1.2.3. Cell Culture
12.3.1.2.4. Isolation
12.3.1.3. Cryopreservation
12.3.1.4. Expansion and Sub-Culture
12.4. Global Stem Cell Therapy Market by Therapeutic Application
12.4.1. Segment Overview
12.4.1.1. Oncology
12.4.1.2. Orthopedic
12.4.1.3. Neurology
12.4.1.4. Cardiovascular & Myocardial Infraction
12.4.1.5. Hematology
12.4.1.6. Others (Wounds & Injuries, Liver Disorders, Diabetes, etc. )
12.5. Global Stem Cell Therapy Market by End Use
12.5.1. Segment Overview
12.5.1.1. Hospitals
12.5.1.2. Research Organizations
12.6. Global Stem Cell Therapy Market by Region
12.6.1. North America
12.6.2. Latin America
12.6.3. Western Europe
12.6.4. Eastern Europe
12.6.5. Asia Pacific
12.6.6. Middle East & Africa
Chapter Thirteen: Regional Analysis
13.1. North America Stem Cell Therapy Market Analysis and Forecast2019-2028
13.1.1. Regional Market Overview and Key Takeaways
13.1.2. North America Stem Cell Therapy Market by Product
13.1.3. North America Stem Cell Therapy Market by Therapy Type
13.1.4. North America Stem Cell Therapy Market by Technology
13.1.5. North America Stem Cell Therapy Market by Therapeutic Application
13.1.6. North America Stem Cell Therapy Market by End Use
13.1.6.1. US
13.1.6.2. Canada
13.2. Latin America Stem Cell Therapy Market Analysis and Forecast2019-2028
13.2.1. Regional Market Overview and Key Takeaways
13.2.2. Latin America Stem Cell Therapy Market by Product
13.2.3. Latin America Stem Cell Therapy Market by Therapy Type
13.2.4. Latin America Stem Cell Therapy Market by Technology
13.2.5. Latin America Stem Cell Therapy Market by Therapeutic Application
13.2.6. Latin America Stem Cell Therapy Market by End Use
13.2.6.1. Brazil
13.2.6.2. Mexico
13.2.6.3. Rest of Latin America
13.3. Western Europe Stem Cell Therapy Market Analysis and Forecast2019-2028
13.3.1. Regional Market Overview and Key Takeaways
13.3.2. Western Europe Stem Cell Therapy Market by Product
13.3.3. Western Europe Stem Cell Therapy Market by Therapy Type
13.3.4. Western Europe Stem Cell Therapy Market by Technology
13.3.5. Western Europe Stem Cell Therapy Market by Therapeutic Application
13.3.6. Western Europe Stem Cell Therapy Market by End Use
13.3.6.1. Germany
13.3.6.2. UK
13.3.6.3. France
13.3.6.4. Spain
13.3.6.5. Italy
13.3.6.6. Benelux
13.3.6.7. Nordic
13.3.6.8. Rest of Western Europe
13.4. Eastern Europe Stem Cell Therapy Market Analysis and Forecast2019-2028
13.4.1. Regional Market Overview and Key Takeaways
13.4.2. Eastern Europe Stem Cell Therapy Market by Product
13.4.3. Eastern Europe Stem Cell Therapy Market by Therapy Type
13.4.4. Eastern Europe Stem Cell Therapy Market by Technology
13.4.5. Eastern Europe Stem Cell Therapy Market by Therapeutic Application
13.4.6. Eastern Europe Stem Cell Therapy Market by End Use
13.4.6.1. Russia
13.4.6.2. Poland
13.4.6.3. Rest of Eastern Europe
13.5. Asia Pacific Stem Cell Therapy Market Analysis and Forecast2019-2028
13.5.1. Regional Market Overview and Key Takeaways
13.5.2. Asia Pacific Stem Cell Therapy Market by Product
13.5.3. Asia Pacific Stem Cell Therapy Market by Therapy Type
13.5.4. Asia Pacific Stem Cell Therapy Market by Technology
13.5.5. Asia Pacific Stem Cell Therapy Market by Therapeutic Application
13.5.6. Asia Pacific Stem Cell Therapy Market by End Use
13.5.6.1. China
13.5.6.2. Japan
13.5.6.3. India
13.5.6.4. South Korea
13.5.6.5. Australia
13.5.6.6. ASEAN
13.5.6.7. Rest of Asia-Pacific
13.6. Middle East & Africa Stem Cell Therapy Market Analysis and Forecast2019-2028
13.6.1. Regional Market Overview and Key Takeaways
13.6.2. Middle East & Africa Stem Cell Therapy Market by Product
13.6.3. Middle East & Africa Stem Cell Therapy Market by Therapy Type
13.6.4. Middle East & Africa Stem Cell Therapy Market by Technology
13.6.5. Middle East & Africa Stem Cell Therapy Market by Therapeutic Application
13.6.6. Middle East & Africa Stem Cell Therapy Market by End Use
13.6.6.1. GCC
13.6.6.2. South Africa
13.6.6.3. Turkey
13.6.6.4. Rest of the Middle East & Africa
Chapter Fourteen: Competitive Landscape
14.1. Competition Dashboard
14.1.1. Global and Regional Market Share Analysis
14.1.2. Market Structure
14.2. Competitive Benchmarking
14.3. Key Strategy Analysis
14.4. Company Profiles
14.4.1. Celgene Corp. (Bristol Myers Squibb)
14.4.1.1. Company Overview
14.4.1.2. Product/Service Offerings
14.4.1.3. Key Financials
14.4.1.4. Recent Developments
14.4.2. ReNeuron Group PLC
14.4.2.1. Company Overview
14.4.2.2. Product/Service Offerings
14.4.2.3. Financials
14.4.2.4. Recent Developments
14.4.3. BioTime Inc.
14.4.3.1. Company Overview
14.4.3.2. Product/Service Offerings
14.4.3.3. Financials
14.4.3.4. Recent Developments
14.4.4. Mesoblast Ltd.
14.4.4.1. Company Overview
14.4.4.2. Product/Service Offerings
14.4.4.3. Financials
14.4.4.4. Recent Developments
14.4.5. Seneca Biopharma Inc.
14.4.5.1. Company Overview
14.4.5.2. Product/Service Offerings
14.4.5.3. Financials
14.4.5.4. Recent Developments
14.4.6. Opexa Therapeutics Inc.
14.4.6.1. Company Overview
14.4.6.2. Product/Service Offerings
14.4.6.3. Financials
14.4.6.4. Recent Developments
14.4.7. Pluristem Therapeutics Inc.
14.4.7.1. Company Overview
14.4.7.2. Product/Service Offerings
14.4.7.3. Financials
14.4.7.4. Recent Developments
14.4.8. STEMCELL Technologies Inc.
14.4.8.1. Company Overview
14.4.8.2. Product/Service Offerings
14.4.8.3. Financials
14.4.8.4. Recent Developments
14.4. 9. ThermoGenesis Holdings Inc.
14.4. 9.1. Company Overview
14.4. 9.2. Product/Service Offerings
14.4. 9.3. Financials
14.4. 9.4. Recent Developments
14.4.10. Astellas Pharma Inc.
14.4.10.1. Company Overview
14.4.10.2. Product/Service Offerings
14.4.10.3. Financials
14.4.10.4. Recent Developments
14.4.11. Caladrius Biosciences Inc.
14.4.11.1. Company Overview
14.4.11.2. Product/Service Offerings
14.4.11.3. Financials
14.4.11.4. Recent Developments
14.4.12. NOVADIP Biosciences S. A.
14.4.12.1. Company Overview
14.4.12.2. Product/Service Offerings
14.4.12.3. Financials
14.4.12.4. Recent Developments
A comprehensive list of stem cell therapy providers will be provided along with geographical reach, employee count, revenue, product capacities, and their capabilities
Chapter Fifteen: Disclaimer

Direct Contact
Jessica Joyal
+1(213)338-8279 | +1(877)376-9989
sales@themarketinsights.com

About us.
Delivering foresights along with statistical analysis of the operational business industry impacts has been our foremost priority. With the constant developments in the research & development industry, we have always challenged the conventional research methodologies and discovered new research tactics to evolve the growing B2B requirements.

This release was published on openPR.